A detailed history of Pitcairn CO transactions in Qiagen N.V. stock. As of the latest transaction made, Pitcairn CO holds 6,568 shares of QGEN stock, worth $266,529. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,568
Previous 7,030 6.57%
Holding current value
$266,529
Previous $305,000 7.54%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$42.19 - $45.27 $19,491 - $20,914
-462 Reduced 6.57%
6,568 $282,000
Q4 2023

Feb 14, 2024

SELL
$35.55 - $43.57 $4,088 - $5,010
-115 Reduced 1.61%
7,030 $305,000
Q3 2023

Nov 13, 2023

BUY
$39.13 - $47.24 $3,952 - $4,771
101 Added 1.43%
7,145 $289,000
Q2 2023

Aug 11, 2023

BUY
$43.93 - $46.76 $2,460 - $2,618
56 Added 0.8%
7,044 $317,000
Q1 2023

May 05, 2023

BUY
$45.29 - $50.76 $13,315 - $14,923
294 Added 4.39%
6,988 $320,000
Q4 2022

Feb 13, 2023

SELL
$41.91 - $50.48 $23,218 - $27,965
-554 Reduced 7.64%
6,694 $333,000
Q3 2022

Nov 10, 2022

BUY
$40.9 - $50.42 $20,163 - $24,857
493 Added 7.3%
7,248 $299,000
Q2 2022

Aug 12, 2022

BUY
$42.98 - $49.77 $3,653 - $4,230
85 Added 1.27%
6,755 $319,000
Q1 2022

May 12, 2022

BUY
$42.23 - $54.3 $1,646 - $2,117
39 Added 0.59%
6,670 $327,000
Q4 2021

Feb 14, 2022

SELL
$50.62 - $56.47 $8,858 - $9,882
-175 Reduced 2.57%
6,631 $369,000
Q3 2021

Nov 10, 2021

BUY
$46.55 - $56.83 $698 - $852
15 Added 0.22%
6,806 $352,000
Q2 2021

Aug 11, 2021

SELL
$46.28 - $52.75 $5,044 - $5,749
-109 Reduced 1.58%
6,791 $329,000
Q1 2021

May 10, 2021

BUY
$46.25 - $56.02 $9,065 - $10,979
196 Added 2.92%
6,900 $336,000
Q4 2020

Feb 05, 2021

BUY
$46.09 - $54.74 $7,374 - $8,758
160 Added 2.44%
6,704 $354,000
Q3 2020

Nov 03, 2020

SELL
$42.51 - $52.42 $42 - $52
-1 Reduced 0.02%
6,544 $342,000
Q2 2020

Jul 28, 2020

BUY
$39.49 - $44.36 $3,870 - $4,347
98 Added 1.52%
6,545 $281,000
Q1 2020

May 13, 2020

SELL
$33.17 - $41.6 $2,321 - $2,912
-70 Reduced 1.07%
6,447 $268,000
Q4 2019

Feb 12, 2020

SELL
$25.41 - $43.1 $6,835 - $11,593
-269 Reduced 3.96%
6,517 $220,000
Q3 2019

Nov 12, 2019

BUY
$32.73 - $40.81 $2,814 - $3,509
86 Added 1.28%
6,786 $224,000
Q2 2019

Aug 12, 2019

SELL
$35.73 - $41.39 $42,232 - $48,922
-1,182 Reduced 15.0%
6,700 $271,000
Q1 2019

May 07, 2019

BUY
$33.78 - $40.68 $48,001 - $57,806
1,421 Added 21.99%
7,882 $321,000
Q4 2018

Feb 12, 2019

SELL
$32.65 - $37.95 $1,469 - $1,707
-45 Reduced 0.69%
6,461 $223,000
Q3 2018

Nov 02, 2018

SELL
$35.99 - $39.39 $50,673 - $55,461
-1,408 Reduced 17.79%
6,506 $247,000
Q2 2018

Aug 02, 2018

SELL
$31.23 - $37.47 $3,060 - $3,672
-98 Reduced 1.22%
7,914 $286,000
Q1 2018

May 11, 2018

SELL
$31.01 - $34.72 $25,831 - $28,921
-833 Reduced 9.42%
8,012 $259,000
Q4 2017

Feb 13, 2018

SELL
$30.68 - $35.37 $153 - $176
-5 Reduced 0.06%
8,845 $274,000
Q3 2017

Nov 03, 2017

BUY
$31.02 - $32.94 $274,527 - $291,519
8,850
8,850 $279,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.24B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Pitcairn CO Portfolio

Follow Pitcairn CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.